The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor

被引:82
|
作者
Di Bacco, A [1 ]
Gill, G [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
cell proliferation; mannose-6-phosphate receptor; NTERA-2; tumor suppressor;
D O I
10.1038/sj.onc.1206670
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Secreted proteins and their cognate receptors are implicated in a myriad of activities that regulate cell proliferation, differentiation, and development. CREG, a cellular repressor of E1A-stimulated genes, is a secreted glycoprotein that antagonizes cellular transformation by E1A and ras. We have previously shown that CREG expression is induced very early during differentiation of pluripotent cells and, even in the absence of other inducers, CREG promotes neuronal differentiation of human teratocarcinoma NTERA-2 cells. Here we show that ectopic expression of CREG in NTERA-2 cells results in a delay of the G1/S phase transition of the cell cycle and growth inhibition. We show that CREG binds directly to the mannose-6-phosphate/insulin-like growth factor II receptor (M6P/IGF2R) dependent on CREG glycosylation. The M6P/IGF2R is a tumor suppressor that functions to control cell growth through interactions with multiple ligands. By analysing CREG activity in cells lacking M6P/IGF2R expression, we show that this receptor is required for CREG-induced growth inhibition. These studies reveal that CREG inhibits cell growth dependent on the M6P/IGF2R and suggest that interactions between CREG and a well-characterized tumor suppressor may contribute to regulation of proliferation and differentiation in multiple lineages.
引用
收藏
页码:5436 / 5445
页数:10
相关论文
共 50 条
  • [1] The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor
    Alessandra Di Bacco
    Grace Gill
    Oncogene, 2003, 22 : 5436 - 5445
  • [2] Increased expression of the mannose 6-phosphate Insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo
    Lee, JS
    Weiss, J
    Martin, JL
    Scott, CD
    INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (04) : 564 - 570
  • [3] MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor
    Xiao, Yao
    Tian, Qinggang
    He, Jiantai
    Huang, Ming
    Yang, Chao
    Gong, Liansheng
    ONCOTARGETS AND THERAPY, 2016, 9 : 3535 - 3544
  • [4] Seasonal expressions of growth hormone receptor, insulin-like growth factor 1 and insulin-like growth factor 1 receptor in the scented glands of the muskrats (Ondatra zibethicus)
    Xie, Wenqian
    Tang, Zeqi
    Guo, Yuanyuan
    Zhang, Chunjiao
    Zhang, Haolin
    Han, Yingying
    Yuan, Zhengrong
    Weng, Qiang
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2019, 281 : 58 - 66
  • [5] Secreted insulin-like growth factor binding protein 5 functions as a tumor suppressor and chemosensitizer through inhibiting insulin-like growth factor 1 receptor/protein kinase B pathway in acute myeloid leukemia
    Zhang, Beiying
    Deng, Xiaoling
    You, Ruolan
    Liu, Jingru
    Hou, Diyu
    Wang, Xiaoting
    Chen, Shucheng
    Li, Dongliang
    Fu, Qiang
    Zhang, Jingdong
    Huang, Huifang
    Chen, Xiaoli
    NEOPLASIA, 2024, 47
  • [6] Insulin-like growth factor binding protein-6 inhibits neuroblastoma and cell proliferation and tumour development
    Seurin, D
    Lassarre, C
    Blenvenu, G
    Babajko, S
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (15) : 2058 - 2065
  • [7] Upregulation of the Insulin Receptor and Type I Insulin-Like Growth Factor Receptor Are Early Events in Hepatocarcinogenesis
    Aleem, Eiman
    Nehrbass, Dirk
    Klimek, Fritz
    Mayer, Doris
    Bannasch, Peter
    TOXICOLOGIC PATHOLOGY, 2011, 39 (03) : 524 - 543
  • [8] Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation
    Bermont, L
    Fauconnet, S
    Lamielle, F
    Adessi, GL
    CELLULAR AND MOLECULAR BIOLOGY, 2000, 46 (07) : 1173 - 1182
  • [9] Insulin-like growth factor-binding protein-6 and cancer
    Bach, Leon A.
    Fu, Ping
    Yang, Zhiyong
    CLINICAL SCIENCE, 2013, 124 (3-4) : 215 - 229
  • [10] DIVERGENT MECHANISMS OF INSULIN-LIKE GROWTH-FACTOR-I AND GROWTH-FACTOR-II ON RAT HEPATOCYTE PROLIFERATION
    RAPER, S
    KOTHARY, P
    ISHOO, E
    DIKIN, M
    KOKUDO, N
    HASHIMOTO, M
    DEMATTEO, RP
    REGULATORY PEPTIDES, 1995, 58 (1-2) : 55 - 62